To further explore the effects of LSD1 inhibition on tumour growth and tumour immune microenvironment in vivo, we constructed a mouse model by subcutaneously injecting with 5×106 h22 cells (Figure 4A). This evidence concerns the gene KDM1A and neoplasm.